Utilizing advanced sequencing and functional assays to map direct phage-human immune crosstalk, with the ultimate goal of harnessing bacteriophages as targeted diagnostic and therapeutic agents.

• Direct Human Interactions: Uncovering how phages directly interact with human cells, bind to mucosal surfaces, and stimulate the immune system.

• Diagnostic Biomarkers: Identifying specific, disease-associated phages circulating in the gut and bloodstream to serve as non-invasive diagnostics.

• Therapeutic Agents: Harnessing phages as precision tools to modulate the microbiome, target pathogens, and treat inflammatory or metabolic diseases.